248 related articles for article (PubMed ID: 32438819)
1. Honokiol Bis-Dichloroacetate Is a Selective Allosteric Inhibitor of the Mitochondrial Chaperone TRAP1.
Sanchez-Martin C; Menon D; Moroni E; Ferraro M; Masgras I; Elsey J; Arbiser JL; Colombo G; Rasola A
Antioxid Redox Signal; 2021 Mar; 34(7):505-516. PubMed ID: 32438819
[No Abstract] [Full Text] [Related]
2. Rational Design of Allosteric and Selective Inhibitors of the Molecular Chaperone TRAP1.
Sanchez-Martin C; Moroni E; Ferraro M; Laquatra C; Cannino G; Masgras I; Negro A; Quadrelli P; Rasola A; Colombo G
Cell Rep; 2020 Apr; 31(3):107531. PubMed ID: 32320652
[TBL] [Abstract][Full Text] [Related]
3. Absence of Neurofibromin Induces an Oncogenic Metabolic Switch via Mitochondrial ERK-Mediated Phosphorylation of the Chaperone TRAP1.
Masgras I; Ciscato F; Brunati AM; Tibaldi E; Indraccolo S; Curtarello M; Chiara F; Cannino G; Papaleo E; Lambrughi M; Guzzo G; Gambalunga A; Pizzi M; Guzzardo V; Rugge M; Vuljan SE; Calabrese F; Bernardi P; Rasola A
Cell Rep; 2017 Jan; 18(3):659-672. PubMed ID: 28099845
[TBL] [Abstract][Full Text] [Related]
4. The mitochondrial chaperone TRAP1 promotes neoplastic growth by inhibiting succinate dehydrogenase.
Sciacovelli M; Guzzo G; Morello V; Frezza C; Zheng L; Nannini N; Calabrese F; Laudiero G; Esposito F; Landriscina M; Defilippi P; Bernardi P; Rasola A
Cell Metab; 2013 Jun; 17(6):988-999. PubMed ID: 23747254
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of succinate dehydrogenase by the mitochondrial chaperone TRAP1 has anti-oxidant and anti-apoptotic effects on tumor cells.
Guzzo G; Sciacovelli M; Bernardi P; Rasola A
Oncotarget; 2014 Dec; 5(23):11897-908. PubMed ID: 25564869
[TBL] [Abstract][Full Text] [Related]
6. Dual Binding to Orthosteric and Allosteric Sites Enhances the Anticancer Activity of a TRAP1-Targeting Drug.
Hu S; Ferraro M; Thomas AP; Chung JM; Yoon NG; Seol JH; Kim S; Kim HU; An MY; Ok H; Jung HS; Ryu JH; Colombo G; Kang BH
J Med Chem; 2020 Mar; 63(6):2930-2940. PubMed ID: 32068404
[TBL] [Abstract][Full Text] [Related]
7. New TRAP1 and Hsp90 chaperone inhibitors with cationic components: Preliminary studies on mitochondrial targeting.
Rondanin R; Lettini G; Oliva P; Baruchello R; Costantini C; Trapella C; Simoni D; Bernardi T; Sisinni L; Pietrafesa M; Ponterini G; Costi MP; Vignudelli T; Luciani R; Matassa DS; Esposito F; Landriscina M
Bioorg Med Chem Lett; 2018 Jul; 28(13):2289-2293. PubMed ID: 29807796
[TBL] [Abstract][Full Text] [Related]
8. Paralog Specificity Determines Subcellular Distribution, Action Mechanism, and Anticancer Activity of TRAP1 Inhibitors.
Park HK; Jeong H; Ko E; Lee G; Lee JE; Lee SK; Lee AJ; Im JY; Hu S; Kim SH; Lee JH; Lee C; Kang S; Kang BH
J Med Chem; 2017 Sep; 60(17):7569-7578. PubMed ID: 28816449
[TBL] [Abstract][Full Text] [Related]
9. The mitochondrial HSP90 paralog TRAP1 forms an OXPHOS-regulated tetramer and is involved in mitochondrial metabolic homeostasis.
Joshi A; Dai L; Liu Y; Lee J; Ghahhari NM; Segala G; Beebe K; Jenkins LM; Lyons GC; Bernasconi L; Tsai FTF; Agard DA; Neckers L; Picard D
BMC Biol; 2020 Jan; 18(1):10. PubMed ID: 31987035
[TBL] [Abstract][Full Text] [Related]
10. TRAP1 regulation of mitochondrial life or death decision in cancer cells and mitochondria-targeted TRAP1 inhibitors.
Kang BH
BMB Rep; 2012 Jan; 45(1):1-6. PubMed ID: 22281005
[TBL] [Abstract][Full Text] [Related]
11. Roles of the Hsp90-Calcineurin Pathway in the Antifungal Activity of Honokiol.
Liao K; Sun L
J Microbiol Biotechnol; 2018 Jul; 28(7):1086-1093. PubMed ID: 29913547
[TBL] [Abstract][Full Text] [Related]
12. The Mitochondrial HSP90 Paralog TRAP1: Structural Dynamics, Interactome, Role in Metabolic Regulation, and Inhibitors.
Joshi A; Ito T; Picard D; Neckers L
Biomolecules; 2022 Jun; 12(7):. PubMed ID: 35883436
[TBL] [Abstract][Full Text] [Related]
13. Tumor Necrosis Factor Receptor-associated Protein 1 (TRAP1) Mutation and TRAP1 Inhibitor Gamitrinib-triphenylphosphonium (G-TPP) Induce a Forkhead Box O (FOXO)-dependent Cell Protective Signal from Mitochondria.
Kim H; Yang J; Kim MJ; Choi S; Chung JR; Kim JM; Yoo YH; Chung J; Koh H
J Biol Chem; 2016 Jan; 291(4):1841-1853. PubMed ID: 26631731
[TBL] [Abstract][Full Text] [Related]
14. Mitoquinone Inactivates Mitochondrial Chaperone TRAP1 by Blocking the Client Binding Site.
Yoon NG; Lee H; Kim SY; Hu S; Kim D; Yang S; Hong KB; Lee JH; Kang S; Kim BG; Myung K; Lee C; Kang BH
J Am Chem Soc; 2021 Dec; 143(47):19684-19696. PubMed ID: 34758612
[TBL] [Abstract][Full Text] [Related]
15. The hsp90-related protein TRAP1 is a mitochondrial protein with distinct functional properties.
Felts SJ; Owen BA; Nguyen P; Trepel J; Donner DB; Toft DO
J Biol Chem; 2000 Feb; 275(5):3305-12. PubMed ID: 10652318
[TBL] [Abstract][Full Text] [Related]
16. HIF1α-dependent induction of the mitochondrial chaperone TRAP1 regulates bioenergetic adaptations to hypoxia.
Laquatra C; Sanchez-Martin C; Dinarello A; Cannino G; Minervini G; Moroni E; Schiavone M; Tosatto S; Argenton F; Colombo G; Bernardi P; Masgras I; Rasola A
Cell Death Dis; 2021 May; 12(5):434. PubMed ID: 33934112
[TBL] [Abstract][Full Text] [Related]
17. Development of a mitochondria-targeted Hsp90 inhibitor based on the crystal structures of human TRAP1.
Lee C; Park HK; Jeong H; Lim J; Lee AJ; Cheon KY; Kim CS; Thomas AP; Bae B; Kim ND; Kim SH; Suh PG; Ryu JH; Kang BH
J Am Chem Soc; 2015 Apr; 137(13):4358-67. PubMed ID: 25785725
[TBL] [Abstract][Full Text] [Related]
18. TRAP1, a novel mitochondrial chaperone responsible for multi-drug resistance and protection from apoptotis in human colorectal carcinoma cells.
Costantino E; Maddalena F; Calise S; Piscazzi A; Tirino V; Fersini A; Ambrosi A; Neri V; Esposito F; Landriscina M
Cancer Lett; 2009 Jun; 279(1):39-46. PubMed ID: 19217207
[TBL] [Abstract][Full Text] [Related]
19. 2.4 Å resolution crystal structure of human TRAP1NM, the Hsp90 paralog in the mitochondrial matrix.
Sung N; Lee J; Kim JH; Chang C; Tsai FT; Lee S
Acta Crystallogr D Struct Biol; 2016 Aug; 72(Pt 8):904-11. PubMed ID: 27487821
[TBL] [Abstract][Full Text] [Related]
20. The molecular chaperone TRAP1 in cancer: From the basics of biology to pharmacological targeting.
Masgras I; Laquatra C; Cannino G; Serapian SA; Colombo G; Rasola A
Semin Cancer Biol; 2021 Nov; 76():45-53. PubMed ID: 34242740
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
